Aspira Pathlab & Diagnostics Limited

About

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics Limited was incorporated in 1973 and is based in Mumbai, India.

Quarterly Results

Rs. Crores · hover row for definition

Metric	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023
Sales	6.17	6.52	5.12	8.09	5.25	5.78	5.41	6.18	4.64	3.82	3.46	3.32	2.60
Expenses	5.83	6.85	6.33	5.90	4.44	4.73	4.65	4.83	4.29	3.95	3.83	3.68	2.92
Operating Profit	0.34	-0.33	-1.21	2.19	0.81	1.05	0.76	1.35	0.35	-0.13	-0.37	-0.36	-0.32
OPM %	5.51	-5.06	-23.63	27.07	15.43	18.17	14.05	21.84	7.54	-3.40	-10.69	-10.84	-12.31
Other Income	0.12	0.14	0.13	0.14	0.11	0.13	0.09	0.08	0.09	0.08	0.10	0.14	0.10
Depreciation	0.41	0.40	0.38	0.40	0.37	0.37	0.39	0.36	0.38	0.38	0.38	0.39	0.39
Interest	0.09	0.10	0.10	0.10	0.09	0.09	0.09	0.08	0.08	0.08	0.09	0.10	0.10
Profit before tax	-0.04	-0.69	-1.56	1.83	0.46	0.72	0.37	0.99	-0.02	-0.51	-0.74	-0.71	-0.71
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit	-0.04	-0.69	-1.56	1.84	0.47	0.72	0.38	0.99	-0.02	-0.50	-0.74	-0.71	-0.72
EPS in Rs	-0.04	-0.67	-1.52	1.79	0.46	0.70	0.37	0.96	-0.02	-0.49	-0.72	-0.69	-0.70

Profit & Loss

Annual · Rs. Crores

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Sales	24.98	22.00	13.20	14.46	19.54	15.21	8.42	7.64	4.36	0.76	0.00	0.00
Expenses	23.52	18.44	14.38	12.86	13.16	11.69	10.25	10.88	8.24	3.34	0.23	0.14
Operating Profit	1.46	3.56	-1.18	1.60	6.38	3.52	-1.83	-3.24	-3.88	-2.58	-0.23	-0.14
OPM %	5.84	16.18	-8.94	11.07	32.65	23.14	-21.73	-42.41	-88.99	-339.47	—	—
Other Income	0.52	0.36	0.42	0.32	0.09	0.20	0.29	0.25	0.22	0.31	0.32	0.21
Interest	0.39	0.35	0.37	0.42	0.37	0.89	1.01	0.96	0.80	0.26	0.05	0.00
Depreciation	1.54	1.49	1.54	1.59	1.64	1.44	1.66	1.23	1.12	0.20	0.00	0.00
Profit before tax	0.05	2.08	-2.67	-0.09	4.46	1.39	-4.21	-5.18	-5.58	-2.73	0.04	0.07
Tax %	0.00	0.00	0.00	0.00	0.00	0.00	0.71	0.00	0.00	0.00	25.00	57.14
Net Profit	0.05	2.07	-2.67	-0.09	4.46	1.38	-4.24	-5.18	-5.58	-2.72	0.03	0.02
EPS in Rs	0.05	2.01	-2.59	-0.09	4.33	1.34	-4.56	-6.32	-10.75	-5.24	0.13	0.09
Dividend Payout %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

Balance Sheet

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015
Equity Capital	10.29	10.29	10.29	10.29	10.29	10.29	9.29	8.19	5.19	5.19	2.25	2.25
Reserves	1.94	-3.01	-5.08	-2.47	-2.43	-6.91	-10.42	-7.93	-4.86	0.72	1.39	1.36
Borrowings	3.32	8.13	7.71	8.24	8.85	7.01	13.80	12.52	11.36	7.29	2.62	0.00
Other Liabilities	2.96	2.11	1.79	1.28	1.42	1.39	1.67	2.02	0.84	1.66	0.03	0.21
Total Liabilities	18.51	17.52	14.71	17.34	18.13	11.78	14.34	14.80	12.53	14.86	6.29	3.82
Fixed Assets	7.20	6.53	6.79	8.01	9.57	7.75	8.70	8.90	7.91	7.79	0.04	0.00
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.25	0.00	0.00
Investments	0.00	0.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	11.31	10.86	7.92	9.33	8.56	4.03	5.64	5.90	4.62	6.82	6.25	3.82
Total Assets	18.51	17.52	14.71	17.34	18.13	11.78	14.34	14.80	12.53	14.86	6.29	3.82

Cash Flows

Annual · Rs. Crores — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Cash from Operating Activity	1.45	1.88	1.05	-0.01	2.03	5.67	-1.87	-3.39	-4.81	-1.29	-0.37
Cash from Investing Activity	-0.80	0.07	0.14	0.16	-0.51	-0.09	0.24	-1.97	-0.77	-10.14	-0.02
Cash from Financing Activity	-1.14	-0.99	-0.95	-0.94	-1.35	-2.17	1.27	3.35	6.52	8.91	2.64
Net Cash Flow	-0.49	0.95	0.24	-0.79	0.17	3.41	-0.35	-2.00	0.94	-2.52	2.25
Free Cash Flow	0.75	1.71	0.79	-0.15	1.42	5.37	-1.92	-3.90	-5.81	-8.41	-0.41
CFO/OP %	99.00	53.00	-89.00	-1.00	32.00	161.00	101.00	105.00	124.00	50.00	139.00

Ratios

Annual · Days / % — latest first

Metric	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016
Debtor Days	25.28	38.99	61.94	59.07	83.87	40.80	26.01	38.22	29.30	43.22	—
Inventory Days	56.53	50.31	62.69	58.40	46.50	51.35	51.36	45.22	103.88	312.86	—
Days Payable	92.06	73.00	101.70	51.10	70.91	91.60	73.37	46.84	64.58	730.00	—
Cash Conversion Cycle	-10.25	16.30	22.93	66.37	59.46	0.55	4.00	36.60	68.61	-373.92	—
Working Capital Days	-4.24	14.10	25.16	48.72	69.30	16.32	-127.01	-96.03	-5.86	-2,199.61	—
ROCE %	2.84	17.37	-15.87	2.01	35.65	19.77	-25.15	-34.49	-38.41	-25.39	1.82

Shareholding Pattern

% holding — latest first

Holder	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	46.58	18.39	18.39	18.39	18.39	18.39	18.55	18.55	18.72	18.72	18.90	18.90
Public	53.41	81.61	81.61	81.61	81.62	81.62	81.46	81.46	81.28	81.29	81.10	81.10
No. of Shareholders	1,620	1,769	1,784	1,755	1,770	1,741	1,593	1,706	1,695	1,512	1,351	1,406